Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (151-160 of 315) with videos related to

Pageof 32
Sort By:
Nature Immunology|March 23, 2021
Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemiasMahesh Raundhal, Shrestha Ghosh, Samuel A Myers, et al.
Cornea|March 28, 2025
Central Cornea Changes on Anterior Segment OCT and In Vivo Confocal Microscopy After Autologous Limbal Epithelial Cell TransplantationLeyla Yavuz Saricay, Aaron R Kaufman, Lynette K Johns, et al.
Blood|January 27, 2009
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host diseaseSarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Blood|November 16, 2017
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host diseaseKathy S Wang, Haesook T Kim, Sarah Nikiforow, et al.
Nature|December 28, 2020
Mechanism of EBV inducing anti-tumour immunity and its therapeutic useIl-Kyu Choi, Zhe Wang, Qiang Ke, et al.
Nature Communications|October 8, 2025
Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft miceFuguo Liu, Mubin Tarannum, Yingjie Zhao, et al.
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2022
Cell-free DNA profiling informs all major complications of hematopoietic cell transplantationAlexandre Pellan Cheng, Matthew Pellan Cheng, Conor James Loy, et al.
Pageof 32

Showing results (151-160 of 315) with videos related to

Sort By:
Pageof 32
Nature Immunology|March 23, 2021
Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemiasMahesh Raundhal, Shrestha Ghosh, Samuel A Myers, et al.
Cornea|March 28, 2025
Central Cornea Changes on Anterior Segment OCT and In Vivo Confocal Microscopy After Autologous Limbal Epithelial Cell TransplantationLeyla Yavuz Saricay, Aaron R Kaufman, Lynette K Johns, et al.
Blood|January 27, 2009
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host diseaseSarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Blood|November 16, 2017
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host diseaseKathy S Wang, Haesook T Kim, Sarah Nikiforow, et al.
Nature|December 28, 2020
Mechanism of EBV inducing anti-tumour immunity and its therapeutic useIl-Kyu Choi, Zhe Wang, Qiang Ke, et al.
Nature Communications|October 8, 2025
Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft miceFuguo Liu, Mubin Tarannum, Yingjie Zhao, et al.
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2022
Cell-free DNA profiling informs all major complications of hematopoietic cell transplantationAlexandre Pellan Cheng, Matthew Pellan Cheng, Conor James Loy, et al.
Pageof 32